India's Central Drugs Standard Control Organisation (CDSCO) has flagged approximately 280 drug batches as Not of Standard Quality (NSQ) in its latest quality surveillance sweep, according to reports in The…
On May 21, 2026, India's Central Drugs Standard Control Organisation (CDSCO) issued a clear directive: no injectable product can be classified or sold as a cosmetic. The directive, reported by…
The Central Drugs Standard Control Organisation (CDSCO) has waived the requirement for local Phase 3 clinical trials for generic versions of lenacapavir, a breakthrough HIV prevention drug, moving India significantly…
India's pharmaceutical industry supplies over 20% of the world's generic medicines by volume. For international buyers — hospitals, pharmacies, procurement agencies, and individual patients — the safety and quality of…